In the balance: how do thrombospondins contribute to the cellular pathophysiology of cardiovascular disease?

Tessa Forbes1, Audrys G Pauza1, Josephine C Adams2

  • 1Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Insights

Thrombospondins (TSPs) are proteins involved in cardiovascular disease (CVD). This review explores TSP roles in CVD, focusing on how genetic variations, or single nucleotide polymorphisms (SNPs), impact cardiovascular health and identifying future research directions.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cardiovascular Research
  • Genetics

Background:

  • Thrombospondins (TSPs) are secreted proteins crucial for cell surface and extracellular matrix interactions.
  • TSPs play significant roles in various cardiovascular diseases (CVD), including stroke, atherosclerosis, and cardiac remodeling.
  • Genetic variations in TSP1 and TSP4 (single nucleotide polymorphisms or SNPs) are linked to increased CVD risk.

Purpose of the Study:

  • To provide an integrative review of Thrombospondins (TSPs) and their functions in cardiovascular disease (CVD).
  • To examine the known properties and mechanisms of TSP single nucleotide polymorphisms (SNPs) relevant to CVD.
  • To identify knowledge gaps and potential future research or translational opportunities concerning TSPs in cardiovascular health.

Main Methods:

  • Integrative literature review of existing research on TSPs and CVD.
  • Analysis of functional roles of TSP family members in cardiovascular cell physiology.
  • Examination of molecular and cellular mechanisms underlying TSP SNP effects in CVD.

Main Results:

  • TSPs are integral to cardiovascular cell physiology and disease processes.
  • Specific TSP SNPs (e.g., in TSP1, TSP4) are associated with heightened CVD risk.
  • The precise molecular basis for differential TSP SNP effects on cardiovascular cells requires further investigation.

Conclusions:

  • TSPs are critical players in cardiovascular health and disease.
  • Understanding TSP SNP mechanisms is vital for assessing CVD risk and developing targeted therapies.
  • Further research is needed to elucidate TSP functions and SNP impacts for translational applications in cardiovascular medicine.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.5K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
80
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
94
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.9K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
185